Skip to main content
Have a personal or library account? Click to login
Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines Cover

Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines

Open Access
|Apr 2021

References

  1. Wang T, Chen L, Yang T, et al. Congenital Heart Disease and Risk of Cardiovascular Disease: A Meta-Analysis of Cohort Studies. J Am Heart Assoc. 2019; 8(10): e012030. DOI: 10.1161/JAHA.119.012030
  2. Wu W, He J, Shao X. Incidence andmortality trend of congenital heart disease at the global, regional, andnational level, 1990–2017. Medicine (Baltimore). 2020; 99(23): e20593. DOI: 10.1097/MD.0000000000020593
  3. Wilamarta KV, Yuniadi Y, Rachmat J, et al. Adult congenital cardiac surgery in Indonesia. Cardiol Young. 2011; 21(6): 639645. DOI: 10.1017/S1047951111000552
  4. Bhatt AB, Foster E, Kuehl K, et al. Congenital heart disease in the older adult: A scientific statement from the American Heart Association [published correction appears in Circulation. 2015 May 26; 131(21): e510]. Circulation. 2015; 131(21): 18841931. DOI: 10.1161/CIR.0000000000000204
  5. D’Alto M, Mahadevan VS. Pulmonary arterial hypertension associated with congenital heart disease. Eur Respir Rev. 2012; 21(126): 328337. DOI: 10.2217/fca-2017-0065
  6. Swinnen K, Quarck R, Godinas L, et al. Learning from registries in pulmonary arterial hypertension: Pitfalls and recommendations. Eur Respir Rev. 2019; 28(154): 190050. DOI: 10.1183/16000617.0050-2019
  7. Dinarti LK, Hartopo AB, Kusuma AD, et al. The COngenitalHeARt Disease in adult and Pulmonary Hypertension (COHARD-PH) registry: A descriptive study from single-center hospital registry of adult congenital heart disease and pulmonary hypertension in Indonesia. BMC Cardiovasc Disord. 2020; 20(1): 163. DOI: 10.1186/s12872-020-01434-z
  8. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019; 53(1): 1801913. DOI: 10.1183/13993003.01913-2018
  9. Idrees M, Butrous G, Mocumbi A, et al. Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward. GlobCardiolSciPract. 2020; 2020(1): e202014. DOI: 10.21542/gcsp.2020.14
  10. Rich S. Primary pulmonary hypertension: executive summary from the World Symposium on Primary Pulmonary Hypertension. Evian, France: World Health Organization, 1998. Retrieved from: http://web.archive.org/web/20020408173726/http://www.who.int/ncd/cvd/pph.html (accessed 04 February 2020).
  11. Sitbon O, Simonneau G. Optimal management of severe pulmonary arterial hypertension. Eur Respir Rev. 2011; 20(122): 254261. DOI: 10.1183/09059180.00007011
  12. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Rev EspCardiol (Engl Ed). 2016; 69(2): 77. DOI: 10.1183/13993003.01032-2015
  13. Desai AA, Machado RF. Diagnostic and therapeutic algorithm for pulmonary arterial hypertension. Pulm Circ. 2011; 1(1): 122124. DOI: 10.4103/2045-8932.78096
  14. Asbarinsyah NA, Soerarso RS, Hersunarti N, et al. Chronic thromboembolic pulmonary hypertension in young woman with history of caesarian section. Med J Indones. 2020; 23(4): 2328. DOI: 10.13181/mji.v23i4.1067
  15. Lai YC, Potoka KC, Champion HC, et al. Pulmonary arterial hypertension: The clinical syndrome. Circ Res. 2014; 115(1): 115130. DOI: 10.1161/CIRCRESAHA.115.301146
  16. Baldi F, Fuso L, Arrighi E, et al. Optimal management of pulmonary arterial hypertension: Prognostic indicators to determine treatment course. Ther Clin Risk Manag. 2014; 10: 825839. DOI: 10.2147/TCRM.S48920
  17. Rosenkranz S, Preston IR. Right heart catheterisation: Best practice and pitfalls in pulmonary hypertension. Eur Respir Rev. 2015; 24(138): 642652. DOI: 10.1183/16000617.0062-2015
  18. Rakhmawati A, Arso IA, Hartopo AB, et al. Functional capacity improvement on patent ductus arteriosus with pulmonary arterial hypertension: A case report and literature review. ACI (Acta Cardiologia Indonesiana). 2019; 5(1): 7179. DOI: 10.22146/aci.44554
  19. Suryantoro M, Anggrahini DW, Hartopo AB, et al. Risk assessment for pulmonary artery hypertension in adult patient with uncorrected atrial septal defect by six-minute walk test and mean pulmonary arterial pressure. ACI (Acta Cardiologia Indonesiana). 2017; 3(2). Suppl S25. DOI: 10.22146/aci.27987
  20. Hartopo AB, Anggrahini DW, Nurdiati DS, et al. Severe pulmonary hypertension and reduced right ventricle systolic function associated with maternal mortality in pregnant uncorrected congenital heart diseases. Pulm Circ. 2019; 9(4). DOI: 10.1177/2045894019884516
  21. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009; 53(17): 15731619. DOI: 10.1161/CIRCULATIONAHA.109.192230
  22. Hidayati F, Gharini PPR, Hartopo AB, et al. The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: A quasi experimental study. Health Qual Life Outcomes. 2020; 18(1): 278. DOI: 10.1186/s12955-020-01498-7
  23. Taichman DB, Ornelas J, Chung L, et al. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. Chest. 2014; 146(2): 449475. DOI: 10.1378/chest.14-0793
  24. Prins KW, Thenappan T. World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology. Cardiol Clin. 2016; 34(3): 363374. DOI: 10.1016/j.ccl.2016.04.001
  25. Dinarti LK, Hartopo AB, Anggrahini DW, et al. Profile of Endothelin-1, Nitric Oxide, and Prostacyclin Levels in Pulmonary Arterial Hypertension Related to Uncorrected Atrial Septal Defect: Results from a Single Center Study in Indonesia. Cardiol Res Pract. 2020; 2020: 7526508. DOI: 10.1155/2020/7526508
  26. Lilyasari O, Subekti Y, Atika N, et al. Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia. BMC Health Serv Res. 2019; 19(1): 573. DOI: 10.1186/s12913-019-4422-5
  27. Hartopo AB, Siswanto BB, Anggrahini DW, et al. Pulmonary artery hypertension patients and the coronavirus disease of 2019 (COVID-19): Are they protected from severe disease? Journal of the Medical Sciences (Berkalailmu Kedokteran). 2020; 52(3): 92101. DOI: 10.19106/JMedSciSI005203202010
  28. Wasir R, Irawati S, Makady A, et al. Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia. PLoS One. 2019; 14(2): e0212328. DOI: 10.1371/journal.pone.0212328
  29. Huddleston AJ, Knoderer CA, Morris JL, et al. Sildenafil for the treatment of pulmonary hypertension in pediatric patients. Pediatr Cardiol. 2009; 30(7): 871882. DOI: 10.4103/0022-3859.159421
  30. Dhariwal AK, Bavdekar SB. Sildenafil in pediatric pulmonary arterial hypertension. J Postgrad Med. 2015; 61(3): 181192. DOI: 10.4103/0022-3859.159421
  31. Rakhmawati A, Achmad IN, Hartopo AB, et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: A randomized-control pilot study. Ann Rehabil Med. 2020 Dec; 44(6): 468480. DOI: 10.5535/arm.20100
  32. Siswanto BB. Pulmonary hypertension in Indonesia: Where and how is the data? What is the gaps? ACI (Acta Cardiologia Indonesiana). 2017; 3(2). DOI: 10.22146/aci.27968
  33. Dinarti LK. Pulmonary hypertension in adult congenital heart disease: From registry to policy. ACI (Acta Cardiologia Indonesiana). 2017; 3(2). DOI: 10.22146/aci.27970
  34. Dinarti LK, Murni IK, Anggrahini DW, et al. The screening of congenital heart disease by cardiac auscultation and 12-lead electrocardiogram among Indonesian elementary school students [published online ahead of print, 2020 Dec 14]. Cardiol Young. 2020; 110. DOI: 10.1017/S1047951120003881
DOI: https://doi.org/10.5334/gh.944 | Journal eISSN: 2211-8179
Language: English
Submitted on: Oct 28, 2020
Accepted on: Mar 26, 2021
Published on: Apr 20, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Lucia Kris Dinarti, Dyah Wulan Anggrahini, Oktavia Lilyasari, Bambang Budi Siswanto, Anggoro Budi Hartopo, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.